Skip to main content
Clinical Trials/NCT00361556
NCT00361556
Completed
Phase 2

Treatment for Nonspecific Low Back Pain in Primary Care With Standardized Health Education Booklets: A Randomized Controlled Clinical Trial

Kovacs Foundation1 site in 1 country240 target enrollmentOctober 2005
ConditionsLow Back Pain

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
Kovacs Foundation
Enrollment
240
Locations
1
Primary Endpoint
Degree of disability at 180 days of follow-up.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The primary purpose of this study is to compare the effectiveness on the disability of low back pain patients of The Back Book, The Back Guide, and a control intervention (generic recommendations on general health). Patients are divided into 3 groups:those who receive The Back Book (classic education), those who receive The Back Guide (cognitive behavioral education) and the control group). They are patients who consult a physician at the primary care consults of 14 different Health Centers in Spain. The sample size is 240 subjects.

Registry
clinicaltrials.gov
Start Date
October 2005
End Date
December 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kovacs Foundation
Responsible Party
Principal Investigator
Principal Investigator

Francisco M. Kovacs

Carmen Fernández, Centro de Salud de Valldargent

Kovacs Foundation

Eligibility Criteria

Inclusion Criteria

  • Low back pain patients,
  • with or without referred or radiated pain;
  • without red flags for systemic disease or criteria for surgery.

Exclusion Criteria

  • Inability to read the handout or to fill out the questionnaires;
  • habitually in a prostrate position;
  • diagnosis of inflammatory rheumatologic disease, cancer or fibromyalgia; suspicion of fibromyalgia.

Outcomes

Primary Outcomes

Degree of disability at 180 days of follow-up.

Time Frame: 6 months

Secondary Outcomes

  • Catastrophizing and days on sick leave at 180 days of follow-up.(6 months)

Study Sites (1)

Loading locations...

Similar Trials